Concord medical reports financial results for the first half of 2022

Beijing , sept. 23, 2022 /prnewswire/ -- concord medical services holdings limited ("concord medical" or the "company") (nyse: ccm), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in china, today announced its unaudited consolidated financial results for the six months ended june 30, 2022[1].
CCM Ratings Summary
CCM Quant Ranking